Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1993 2
1996 1
1997 2
1998 2
1999 2
2001 1
2002 2
2004 1
2005 1
2007 2
2008 1
2010 2
2011 1
2012 1
2013 3
2014 2
2015 2
2016 2
2017 1
2018 1
2019 2
2021 3
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Myxoinflammatory Fibroblastic Sarcoma.
Wu H, Laskin WB. Wu H, et al. Surg Pathol Clin. 2024 Mar;17(1):83-96. doi: 10.1016/j.path.2023.07.003. Epub 2023 Aug 8. Surg Pathol Clin. 2024. PMID: 38278610 Review.
Large epithelioid cells harboring bizarre nuclei and virocyte-like macronucleoli and pleomorphic pseudolipoblasts are characteristic. While conventional MIFS has locally recurrent potential but minimal metastatic risk, tumors with high-grade histologic features have a grea …
Large epithelioid cells harboring bizarre nuclei and virocyte-like macronucleoli and pleomorphic pseudolipoblasts are characteristic. While …
Dermatofibrosarcoma protuberans.
Serra-Guillén C, Llombart B, Sanmartín O. Serra-Guillén C, et al. Actas Dermosifiliogr. 2012 Nov;103(9):762-77. doi: 10.1016/j.ad.2011.10.007. Epub 2012 Jan 28. Actas Dermosifiliogr. 2012. PMID: 22285046 Free article. Review. English, Spanish.
A review of the literature provides evidence that recurrence is much lower after Mohs micorgraphic surgery than after conventional wide local excision. In the case of metastatic disease or when surgery would be mutilating, another recently approved treatment is the tyrosin …
A review of the literature provides evidence that recurrence is much lower after Mohs micorgraphic surgery than after conventional wi …
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C, Larousserie F, De Percin S, Audard V, Hadjadj D, Chen J, Biau D, Anract P, Terris B, Goldwasser F, Pasmant E, Boudou-Rouquette P. Tlemsani C, et al. Int J Mol Sci. 2023 Jan 10;24(2):1361. doi: 10.3390/ijms24021361. Int J Mol Sci. 2023. PMID: 36674874 Free PMC article. Review.
Central and peripheral CS differ at the molecular level with either IDH1/2 mutations or EXT1/2 mutations, respectively. CDKN2A/B deletions are also frequent in conventional CS, as well as COL2A1 mutations. Dedifferentiated CS develops when low-grade conventional CS …
Central and peripheral CS differ at the molecular level with either IDH1/2 mutations or EXT1/2 mutations, respectively. CDKN2A/B deletions a …
Resveratrol in management of bone and spinal cancers.
Chen G, Xia H, Zhang ZG, Yu HL. Chen G, et al. Nat Prod Res. 2019 Feb;33(4):516-526. doi: 10.1080/14786419.2017.1389936. Epub 2017 Oct 20. Nat Prod Res. 2019. PMID: 29052449 Review.
Bone cancer is a malignant primary tumour of the bone with different typing, such as, osteosarcoma, chondrosarcoma, Ewing's sarcoma and fibrosarcoma. Despite the clinical efficacy of conventional therapies of bone cancer, most patients eventually relapse and the dis …
Bone cancer is a malignant primary tumour of the bone with different typing, such as, osteosarcoma, chondrosarcoma, Ewing's sarcoma and f
The evolution of systemic therapy in sarcoma.
Constantinidou A, Pollack S, Loggers E, Rodler E, Jones RL. Constantinidou A, et al. Expert Rev Anticancer Ther. 2013 Feb;13(2):211-23. doi: 10.1586/era.12.161. Expert Rev Anticancer Ther. 2013. PMID: 23406562 Review.
Approximately 50% of patients with localized soft tissue sarcomas will develop recurrent disease after complete surgical resection, requiring alternative means of treatment. Conventional chemotherapy comprising of doxorubicin and ifosfamide has shown benefit in advanced di …
Approximately 50% of patients with localized soft tissue sarcomas will develop recurrent disease after complete surgical resection, requirin …
Metastatic pediatric sclerosing epithelioid fibrosarcoma.
Woods AD, Purohit R, Mitchell LC, Collier JR, Collier KA, Lathara M, Learned K, Vaske O, Geiger H, Wrzeszczynski KO, Jobanputra V, Srinivasa G, Rudzinski ER, Whelan K, Beierle E, Spunt SL, Keller C, Wadhwa A. Woods AD, et al. Cold Spring Harb Mol Case Stud. 2021 Oct 19;7(5):a006093. doi: 10.1101/mcs.a006093. Print 2021 Oct. Cold Spring Harb Mol Case Stud. 2021. PMID: 34362827 Free PMC article. Review.
Sclerosing epithelioid fibrosarcoma (SEF) is a rare and aggressive soft-tissue sarcoma thought to originate in fibroblasts of the tissues comprising tendons, ligaments, and muscles. Minimally responsive to conventional cytotoxic chemotherapies, >50% of SEF patien …
Sclerosing epithelioid fibrosarcoma (SEF) is a rare and aggressive soft-tissue sarcoma thought to originate in fibroblasts of the tis …
Dermatofibrosarcoma protuberans in pregnancy: a case series and review of the literature.
Kibbi N, Wang D, Wang WL, Galan A, Leffell DJ, Christensen SR, Panse G. Kibbi N, et al. Int J Dermatol. 2021 Sep;60(9):1114-1119. doi: 10.1111/ijd.15497. Epub 2021 Apr 5. Int J Dermatol. 2021. PMID: 33818755 Review.
Ten tumors (55.6%) were located on the trunk, four (22.2%) on the head and neck, three (16.7%) on the extremities, and one (5.6%) in the genitalia. Most tumors demonstrated features of conventional DFSP (12/18, 66.7%), while the remaining were identified as DFSP with fibro …
Ten tumors (55.6%) were located on the trunk, four (22.2%) on the head and neck, three (16.7%) on the extremities, and one (5.6%) in the gen …
[Dermatofibrosarcoma protuberans].
Sanmartín O, Llombart B, López-Guerrero JA, Serra C, Requena C, Guillén C. Sanmartín O, et al. Actas Dermosifiliogr. 2007 Mar;98(2):77-87. doi: 10.1016/s0001-7310(07)70019-4. Actas Dermosifiliogr. 2007. PMID: 17397592 Free article. Review. Spanish.
Treatment of localized disease consists in complete surgical excision of the lesion by conventional surgery with wide margins (>3 cm) or by micrographic Mohs surgery. ...
Treatment of localized disease consists in complete surgical excision of the lesion by conventional surgery with wide margins (>3 …
Clinical applications of PET and PET/CT in pediatric malignancies.
Kumar R, Shandal V, Shamim SA, Halanaik D, Malhotra A. Kumar R, et al. Expert Rev Anticancer Ther. 2010 May;10(5):755-68. doi: 10.1586/era.10.12. Expert Rev Anticancer Ther. 2010. PMID: 20470007 Review.
Usually the conventional imaging modalities, such as x-ray, ultrasound, computed tomography (CT) and MRI, are being routinely used for the management of these pediatric malignancies. ...Despite the fact that PET/CT has better diagnostic value when compared with conventi
Usually the conventional imaging modalities, such as x-ray, ultrasound, computed tomography (CT) and MRI, are being routinely used fo …
Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K, Noujaim J, Jones RL, Fisher C. Thway K, et al. Ann Diagn Pathol. 2016 Dec;25:64-71. doi: 10.1016/j.anndiagpath.2016.09.013. Epub 2016 Sep 27. Ann Diagn Pathol. 2016. PMID: 27806849 Review.
Dermatofibrosarcoma protuberans is generally regarded as refractory to conventional chemotherapy. Treatment options for systemic disease have been previously limited, but the PDGFbetaR, KIT, and ABL inhibitor imatinib is now an option for effective systemic therapy. ...
Dermatofibrosarcoma protuberans is generally regarded as refractory to conventional chemotherapy. Treatment options for systemic dise …
38 results